Results 221 to 230 of about 749,373 (347)
Can Symptom Clusters Predict Stage, Resectability, and Survival in Pancreatic Cancer? [PDF]
Demir MS, Ağdaş G.
europepmc +1 more source
tRF‐22 fosters an immunosuppressive and pro‐oncogenic tumor microenvironment in ESCC by stabilizing hnRNPAB against TRIM25‐mediated ubiquitination and enhancing TGFβ2 expression, which increases PMN‐MDSCs infiltration and suppresses CD8+ T cells. Targeting tRF‐22 or blocking TGFβ signalling improves anti‐PD1 response, offering a promising therapeutic ...
Ling Pan +10 more
wiley +1 more source
Deciphering the liver's role in pancreatic cancer metastasis: pathways and therapeutic approaches. [PDF]
Inzunza J, Del Valle AC.
europepmc +1 more source
This study identifies SPTAN1‐kla as a novel oncogenic driver in HBV‐driven HCC, linking metabolic, epigenetic, and immune mechanisms. SPTAN1‐kla promotes HCC progression via NOTCH1/HES1 activation and immunosuppression. Findings highlight that targeting SPTAN1‐kla provides a framework for HCC treatment to improve clinical outcomes in HBV infected ...
Zengbin Wang +8 more
wiley +1 more source
Pancreatic Cancer in Cystic Fibrosis: Is the Incidence Increasing? [PDF]
Markham R, Wright BA, Pena T.
europepmc +1 more source
This study demonstrates that Mn2⁺–tumor DNA complexes encapsulated in dendritic cell (DC)– derived immunogenic extracellular vesicles (EVDC@Mn‐DNA) act as a DC‐specific cGAS– STING activator. EVDC@Mn‐DNA treatment enhances intratumoral DC activation, improves tumor vascular function, promotes CD8⁺ T cell activity, and suppresses pancreatic tumor growth,
Xue Jiang +13 more
wiley +1 more source
Tryptophan metabolism in pancreatic cancer: A review. [PDF]
Gao Y, Yang L, Wang X.
europepmc +1 more source
Dysplastic nevus syndrome and pancreatic cancer: A case report
Liliana Gabriela Popa +8 more
openalex +2 more sources

